Does Ozempic List Pancreatitis as a Side Effect?
Yes, acute pancreatitis is listed in Ozempic's (semaglutide) FDA-approved prescribing information as a serious warning and precaution. The label states that acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists like Ozempic. It instructs healthcare providers to monitor for signs and symptoms of pancreatitis, such as persistent severe abdominal pain that may radiate to the back and may or may not be accompanied by vomiting, and to discontinue the drug if suspected.[1]
How Common Is Pancreatitis with Ozempic?
The Ozempic label reports pancreatitis in 0.3% of patients in clinical trials (7 cases out of 2,282), compared to 0.1% on placebo. Post-marketing reports have noted acute pancreatitis, though causality is not always confirmed. No increased risk was seen in long-term cardiovascular outcome trials.[1]
What Do Patients Experience with Pancreatitis Symptoms?
Symptoms include severe abdominal pain, nausea, vomiting, and elevated pancreatic enzymes. The label notes cases can be severe or fatal, and Ozempic should not be restarted if pancreatitis is confirmed. Patients with a history of pancreatitis may be at higher risk, though data is limited.[1]
How Does This Compare to Other GLP-1 Drugs Like Wegovy or Mounjaro?
Ozempic's warning aligns with the class-wide FDA label for GLP-1 agonists. Wegovy (also semaglutide) carries the identical pancreatitis warning. Mounjaro (tirzepatide) lists acute pancreatitis similarly, occurring in 0.2% of patients in trials versus 0% on placebo.[2][3]
What Regulatory Actions Address Pancreatitis Risks?
The FDA added pancreatitis to GLP-1 labels in 2011 after post-marketing reports with exenatide (Byetta). Ozempic's approval in 2017 included this warning from the start. Ongoing monitoring continues via FDA's Adverse Event Reporting System (FAERS), which logs hundreds of pancreatitis cases linked to semaglutide.[1]
Can You Take Ozempic If You've Had Pancreatitis Before?
The label advises against use in patients with a prior history of pancreatitis due to lack of safety data. Providers weigh risks individually, often opting for alternatives.[1]
[1] Ozempic Prescribing Information (FDA, latest label)
[2] Wegovy Prescribing Information (FDA)
[3] Mounjaro Prescribing Information (FDA)